Revisiting ribonucleotide reductase as a target to enhance radiation and chemotherapy anti-tumor activity.
作者信息
Sznol Mario
机构信息
Vion Pharmaceuticals, Inc., New Haven, Connecticut 06511, USA.
出版信息
Cancer J. 2003 Jul-Aug;9(4):247-50. doi: 10.1097/00130404-200307000-00006.
Abstract
摘要
Zotero 插件